Literature DB >> 27692294

Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing.

E Lorge1, M M Moore2, J Clements3, M O'Donovan4, M D Fellows5, M Honma6, A Kohara7, S Galloway8, M J Armstrong8, V Thybaud9, B Gollapudi10, M J Aardema11, J Y Tanir12.   

Abstract

Good cell culture practice and characterization of the cell lines used are of critical importance in in vitro genotoxicity testing. The objective of this initiative was to make continuously available stocks of the characterized isolates of the most frequently used mammalian cell lines in genotoxicity testing anywhere in the world ('IVGT' cell lines). This project was organized under the auspices of the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) Project Committee on the Relevance and Follow-up of Positive Results in In Vitro Genetic Toxicity (IVGT) Testing. First, cell isolates were identified that are as close as possible to the isolate described in the initial publications reporting their use in genotoxicity testing. The depositors of these cell lines managed their characterization and their expansion for preparing continuously available stocks of these cells that are stored at the European Collection of Cell Cultures (ECACC, UK) and the Japanese Collection of Research Bioresources (JCRB, Japan). This publication describes how the four 'IVGT' cell lines, i.e. L5178Y TK+/- 3.7.2C, TK6, CHO-WBL and CHL/IU, were prepared for deposit at the ECACC and JCRB cell banks. Recommendations for handling these cell lines and monitoring their characteristics are also described. The growth characteristics of these cell lines (growth rates and cell cycles), their identity (karyotypes and genetic status) and ranges of background frequencies of select endpoints are also reported to help in the routine practice of genotoxicity testing using these cell lines.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3.7.2C; CHL/IU; CHO-WBL; Cells; Genotoxicity; L5178Y TK(+/−); TK6

Mesh:

Substances:

Year:  2016        PMID: 27692294     DOI: 10.1016/j.mrgentox.2016.08.001

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

1.  The expression of Phase II drug-metabolizing enzymes in human B-lymphoblastoid TK6 cells.

Authors:  Xilin Li; Yuxi Li; Kylie G Ning; Si Chen; Lei Guo; Jessica A Bonzo; Nan Mei
Journal:  J Environ Sci Health C Toxicol Carcinog       Date:  2022-03-11

2.  Development and Application of TK6-derived Cells Expressing Human Cytochrome P450s for Genotoxicity Testing.

Authors:  Xilin Li; Si Chen; Xiaoqing Guo; Qiangen Wu; Ji-Eun Seo; Lei Guo; Mugimane G Manjanatha; Tong Zhou; Kristine L Witt; Nan Mei
Journal:  Toxicol Sci       Date:  2020-06-01       Impact factor: 4.849

3.  The genotoxicity potential of luteolin is enhanced by CYP1A1 and CYP1A2 in human lymphoblastoid TK6 cells.

Authors:  Xilin Li; Xiaobo He; Si Chen; Yuan Le; Matthew S Bryant; Lei Guo; Kristine L Witt; Nan Mei
Journal:  Toxicol Lett       Date:  2021-03-13       Impact factor: 4.271

4.  The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part II: Assay performance for the identification of mutagenic chemicals.

Authors:  Julie A Cox; Edwin P Zwart; Mirjam Luijten; Paul A White
Journal:  Environ Mol Mutagen       Date:  2019-02-25       Impact factor: 3.216

5.  Comparative study of cytotoxic effects induced by environmental genotoxins using XPC- and CSB-deficient human lymphoblastoid TK6 cells.

Authors:  Akira Sassa; Takayuki Fukuda; Akiko Ukai; Maki Nakamura; Michihito Takabe; Takeji Takamura-Enya; Masamitsu Honma; Manabu Yasui
Journal:  Genes Environ       Date:  2019-07-16

Review 6.  Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far.

Authors:  Sandra Jesus; Mélanie Schmutz; Claudia Som; Gerrit Borchard; Peter Wick; Olga Borges
Journal:  Front Bioeng Biotechnol       Date:  2019-10-23

7.  A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms.

Authors:  Bernadett Szikriszt; Ádám Póti; Eszter Németh; Nnennaya Kanu; Charles Swanton; Dávid Szüts
Journal:  Mutagenesis       Date:  2021-04-28       Impact factor: 3.000

8.  Thymidine Kinase+/- Mammalian Cell Mutagenicity Assays for Assessment of Nanomaterials.

Authors:  Tao Chen; Maria Dusinska; Rosalie Elespuru
Journal:  Front Toxicol       Date:  2022-06-08

9.  Enhancing the sensitivity of the thymidine kinase assay by using DNA repair-deficient human TK6 cells.

Authors:  Mahmoud Abdelghany Ibrahim; Manabu Yasui; Liton Kumar Saha; Hiroyuki Sasanuma; Masamitsu Honma; Shunichi Takeda
Journal:  Environ Mol Mutagen       Date:  2020-04-15       Impact factor: 3.216

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.